| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_443d491bc96b073f9a30d903320015e1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07 |
| filingDate |
1972-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1974-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2192817-A1 |
| titleOfInvention |
Vincamine and vitamin p compsns - cerebral vasodilators and vascular protective |
| abstract |
The compsn. is administered in unit doses contg. 0.005-0.050g of vincamine and 0.005-0.050g of vitamin P factor. The vitamin P factor is chosen from natural, semi-synthetic or synthetic coumarins and flavanoids such as rutin, hesperidin, eriodictin, and esculoside. |
| priorityDate |
1972-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |